As global markets navigate a mix of rising stock indices and declining consumer confidence, investors are increasingly focused on strategies that offer stability amidst economic uncertainty. In this environment, dividend stocks can provide a reliable income stream, making them an attractive option for those looking to balance growth with consistent returns.
Name |
Dividend Yield |
Dividend Rating |
Guaranty Trust Holding (NGSE:GTCO) |
6.49% |
★★★★★★ |
Peoples Bancorp (NasdaqGS:PEBO) |
5.05% |
★★★★★★ |
Tsubakimoto Chain (TSE:6371) |
4.09% |
★★★★★★ |
CAC Holdings (TSE:4725) |
4.84% |
★★★★★★ |
Yamato Kogyo (TSE:5444) |
4.04% |
★★★★★★ |
GakkyushaLtd (TSE:9769) |
4.38% |
★★★★★★ |
Nihon Parkerizing (TSE:4095) |
3.83% |
★★★★★★ |
FALCO HOLDINGS (TSE:4671) |
6.38% |
★★★★★★ |
E J Holdings (TSE:2153) |
3.82% |
★★★★★★ |
Premier Financial (NasdaqGS:PFC) |
4.85% |
★★★★★★ |
Click here to see the full list of 1942 stocks from our Top Dividend Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Dubai Refreshment (P.J.S.C.) is involved in the bottling and selling of Pepsi Cola International products across Dubai, Sharjah, and the Northern Emirates of the UAE, with a market cap of AED2.16 billion.
Operations: The company’s revenue primarily comes from the wholesale of groceries, amounting to AED808.51 million.
Dividend Yield: 3.3%
Dubai Refreshment (P.J.S.C.) presents a mixed dividend picture. While dividends are covered by earnings and cash flows with payout ratios at 56.6% and 45.1%, respectively, the dividend yield of 3.33% is below top-tier levels in the AE market. The company’s dividend payments have been volatile over the past decade but show growth trends despite an unreliable track record. Recent earnings showed a decline in net income, impacting potential future payouts amidst illiquid shares and internal discussions underway.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market cap of SEK11.32 billion.
Operations: BioGaia AB (publ) generates revenue primarily from its Pediatrics segment, which accounts for SEK1.04 billion, and its Adult Health segment, contributing SEK306.08 million.
Dividend Yield: 6.2%
BioGaia’s dividend yield is among the top 25% in Sweden, yet its sustainability is questionable due to high cash payout ratios of 191.2%, indicating dividends aren’t well-covered by cash flows. Despite a reasonable earnings payout ratio of 57%, past decade payments have been volatile and unreliable. Recent earnings reveal decreased net income, which may affect future payouts despite ongoing product innovations like BioGaia® Gastrus® PURE ACTION aimed at expanding market reach and improving digestive health solutions.